|
1
|
Sager GF: Primary malignant tumors of the
small intestine. A twenty-two year experience with thirty patients.
Am J Surg. 135:601–603. 1978.PubMed/NCBI
|
|
2
|
Ciccarelli O, Welch JP and Kent GG:
Primary malignant tumors of the small bowel. The Hartford Hospital
experience, 1969–1983. Am J Surg. 153:350–354. 1987.PubMed/NCBI
|
|
3
|
Jemal A, Murray T, Ward E, et al: Cancer
statistics. CA Cancer J Clin. 55:2592005.
|
|
4
|
Kusumoto H, Takahashi I, Yoshida M, et al:
Primary malignant tumors of the small intestine: analysis of 40
Japanese patients. J Surg Oncol. 50:139–143. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dabaja BS, Suki D, Pro B, Bonnen M and
Ajani J: Adenocarcinoma of the small bowel: presentation,
prognostic factors and outcome of 217 patients. Cancer.
101:518–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Polyzos A, Kouraklis G, Giannopoulos A,
Bramis J, Delladetsima JK and Sfikakis PP: Irinotecan as salvage
chemotherapy for advanced small bowel adenocarcinoma: a series of
three patients. J Chemother. 15:503–506. 2003.PubMed/NCBI
|
|
7
|
Jigyasu D, Bedikian AY and Stroehlein JR:
Chemotherapy for primary adenocarcinoma of the small bowel. Cancer.
53:23–25. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Onodera H, Nishitai R, Shimizu K, Maetani
S and Imamura M: Small intestinal cancer with extensive lymph node
metastases showing complete remission by
methotrexate/5-fluorouracil sequential therapy: report of a case.
Surg Today. 27:60–63. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lioe TF and Biggart JD: Primary
adenocarcinoma of the jejunum and ileum: clinicopathological review
of 25 cases. J Clin Pathol. 43:533–536. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Talamonti MS, Goetz LH, Rao S and Joehl
RJ: Primary cancers of the small bowel: analysis of prognostic
factors and results of surgical management. Arch Surg. 137:564–571.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Overman MJ, Kopetz S, Wen S, et al:
Chemotherapy with 5-fluorouracil and a platinum compound improves
outcomes in metastatic small bowel adenocarcinoma. Cancer.
113:2038–2045. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fishman PN, Pond GR, Moore MJ, et al:
Natural history and chemotherapy effectiveness for advanced
adenocarcinoma of the small bowel: a retrospective review of 113
cases. Am J Clin Oncol. 29:225–231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gibson MK, Holcroft CA, Kvols LK and
Haller D: Phase II study of 5-fluorouracil, doxorubicin and
mitomycin C for metastatic small bowel adenocarcinoma. Oncologist.
10:132–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Overman MJ, Varadhachary GR, Kopetz S, et
al: Phase II study of capecitabine and oxaliplatin for advanced
adenocarcinoma of the small bowel and ampulla of Vater. J Clin
Oncol. 27:2598–2603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ono M, Shirao K, Takashima A, et al:
Combination chemotherapy with cisplatin and irinotecan in patients
with adenocarcinoma of the small intestine. Gastric Cancer.
11:251–255. 2008.PubMed/NCBI
|
|
16
|
Saltz LB, Douillard JY, Pirotta N, Alakl
M, Gruia G, Awad L, Elfring GL, Locker PK and Miller LL: Irinotecan
plus fluorouracil/leucovorin for metastatic colorectal cancer: a
new survival standard. Oncologist. 6:81–91. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fujishima H, Kikuchi I, Miyanaga O, Ueda
A, Baba E, Mitsugi K, Harada M and Nakano S: Phase I study of
CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic
colorectal cancer. Int J Clin Oncol. 9:92–97. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujishima H, Makiyama A, Miyanaga O, Ueda
A, Esaki T, Mitsugi K, Baba E, Kusaba H, Harada M and Nakano S: A
multicenter phaseIIstudy of irinotecan (CPT-11) and bolus
5-fluorouracil (5FU)/l-leucovorin(l-LV) in patients with metastatic
colorectal cancer. J Clin Oncol, 2005 ASCO Annual Meeting
Proceedings. 23(16): Part I of II. 37422005.
|
|
19
|
Di Marco L, Berghenti M and Felloni M:
Primary adenocarcinoma of the second portion of duodenum. Ann Ital
Chir. 74:573–577. 2003.PubMed/NCBI
|
|
20
|
Zhou Z, Wan D and Shi M: Diagnosis and
treatment of primary malignant tumors of the small bowel. Zhonghua
Zhong Liu Za Zhi. 19:297–299. 1997.PubMed/NCBI
|
|
21
|
Goldberg RM, Sargent DJ, Morton RF, Fuchs
CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC and Alberts
SR: A randomized controlled trial of fluorouracil plus leucovorin,
irinotecan and oxaliplatin combinations in patients with previously
untreated metastatic colorectal cancer. J Clin Oncol. 22:23–30.
2004. View Article : Google Scholar
|
|
22
|
Tournigand C, Andre T, Achille E, Lledo G,
Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G,
Landi B, Colin P, Louvet C and de Gramont A: FOLFIRI followed by
FOLFOX6 or the reverse sequence in advanced colorectal cancer: a
randomized GERCOR study. J Clin Oncol. 22:229–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
